- Thread Author
- #1
The World Health Organization (WHO) on Monday, October 13, issued a medical product alert for three cough and cold syrups identified in India, advising national regulators worldwide to notify the agency if the medicines are found in their markets and to step up targeted surveillance, especially in informal supply chains.
The affected products are specific batches of Coldrif (Sresan Pharmaceutical), Respifresh TR (Rednex Pharmaceuticals), and ReLife (Shape Pharma). India’s Central Drugs Standard Control Organization (CDSCO) told WHO on October 8, 2025 that laboratory tests detected diethylene glycol (DEG) in at least three oral liquid medicines, with the toxic solvent present at levels “nearly 500 times the permissible limit.” CDSCO said the syrups were reportedly consumed by children under five who recently died in Chhindwara, Madhya Pradesh.
The affected products are specific batches of Coldrif (Sresan Pharmaceutical), Respifresh TR (Rednex Pharmaceuticals), and ReLife (Shape Pharma). India’s Central Drugs Standard Control Organization (CDSCO) told WHO on October 8, 2025 that laboratory tests detected diethylene glycol (DEG) in at least three oral liquid medicines, with the toxic solvent present at levels “nearly 500 times the permissible limit.” CDSCO said the syrups were reportedly consumed by children under five who recently died in Chhindwara, Madhya Pradesh.
